Adam Dixon: How AI-Powered Ultrasound Can Optimize Neuraxial Anesthesia for Anticoagulated Patients
Adam Dixon, Chief Technology Officer of RIVANNA, shared a post on LinkedIn:
“Administering neuraxial anesthesia in patients on anticoagulants presents a nuanced risk profile, particularly when it comes to the potential for spinal hematomas. When the timing and management of anticoagulants aren’t fully aligned with procedural guidelines, anticoagulation therapy can increase the likelihood of bleeding during epidural and spinal anesthesia.
The question is: How can we better mitigate these risks while ensuring optimal pain management?
Neuraxial techniques offer localized pain relief, generally considered safer than general anesthesia for people taking anticoagulants. This helps to decrease the perioperative risk of blood clots, effectively lowering the demand for systemic anticoagulants postoperatively. Ultrasound guidance can enhance precision by providing high-resolution imaging of vascular structures and anatomical landmarks. And by improving pre-procedural planning in this way, ultrasound helps reduce the likelihood of vascular complications, supporting safer outcomes.

AI-powered ultrasound can improve precision in neuraxial anesthesia for patients on anticoagulants. Visit here to learn more.”
Discover the latest on Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026